All In Biotech

Drug Trial Radar · NCT07640893

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

A Multi-Dose, Randomized, Multicenter Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of SR604 Injection in Patients With Von Willebrand Disease

Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Nov 26, 2025

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Sponsor type
Industry
First posted
Jun 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.

Conditions

  • Von Willebrand Disease (VWD)

Interventions

  • SR604Drug

    SR604 will be administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total annualized bleeding rate (ABR) after treatmentTime frame: From baseline, through study completion, an average of 52 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Xiangya Hospital of Central South University

    Changsha, China · Recruiting

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, China · Recruiting

  • Jinan Central Hospital

    Jinan, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, China · Recruiting

  • The First Affiliated Hospital of Soochow University

    Suzhou, China · Recruiting

  • The Second Hospital of Shanxi Medical University

    Taiyuan, China · Recruiting

  • North China University of Science and Technology Affiliated Hospital

    Tangshan, China · Recruiting

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

    Tianjin, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.